Related Experiment Videos
[Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)]
Insights
Dobutamine at 5 mcg/Kg/min significantly improved cardiac function in severe heart failure patients. This dose enhanced cardiac index and reduced filling pressures without major side effects, unlike higher doses.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Context:
- Severe chronic heart failure (CHF) management remains challenging.
- Understanding drug-induced hemodynamic changes is crucial for patient care.
Purpose:
- To evaluate the hemodynamic effects of dobutamine in patients with severe chronic heart failure.
- To determine the optimal dobutamine dosage for therapeutic benefit without adverse events.
Summary:
- Dobutamine was administered to 10 severe CHF patients at 2.5, 5, and 7.5 mcg/Kg/min.
- The 5 mcg/Kg/min dose significantly increased cardiac index and left ventricle stroke work index.
- This dose also decreased filling pressures and vascular resistance, with effects waning 5-10 minutes post-infusion.
Impact:
- Dobutamine at 5 mcg/Kg/min demonstrates potent positive inotropic effects with a favorable safety profile in severe heart failure.
- Higher doses (7.5 mcg/Kg/min) may increase the risk of arrhythmias, such as premature ventricular beats.
- Findings support the use of individualized dobutamine dosing for optimizing hemodynamic support in heart failure.
Abstract:
We studied the hemodynamic effects of dobutamine in 10 patients with severe chronic heart failure due to congestive cardiomyopathy in 5, to ischemic heart disease in 4 and to hypertensive cardiomyopathy in 1. Dobutamine was injected during three periods of 30 min each alternated with equal periods of placebo at doses of 2,5-5 and 7,5 mcg/Kg/min respectively. The most favorable hemodynamic effects, obtained at an infusion rate of 5 mcg/Kg/min, was characterized by a significant inn 4 and to hypertensive cardiomyopathy in 1. Dobutamine was injected during three periods of 30 min each alternated with equal periods of placebo at doses of 2,5-5 and 7,5 mcg/Kg/min respectively. The most favorable hemodynamic effects, obtained at an infusion rate of 5 mcg/Kg/min, was characterized by a significant increase of the cardiac index and of the left ventricle stroke work index, accompanied by a significant decrease of the left ventricular filling pressure and of the systemic and pulmonary vascular resistance. The hemodynamic monitoring showed that the pharmacological effects of the drug subsided about 5-10 min after the interruption of infusion. At the infusion rate of 7,5 mcg/Kg/min we observed a significant increase of premature ventricular beats in 3 patients. We conclude that dobutamine at the dose of 5 mcg/Kg/min shows a powerfull positive inotropic action not accompanied by apparent side effects.